Skip to main content

Table 3 PET Imaging Response Rates

From: FDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinoma

Treatment

Metabolic Assessment

Proliferative Assessment

Cohort

PR

SD

PD

PR

SD

PD

Week 1

0/4 (0 %)

3/4 (75 %)

1/4 (25 %)

2/4 (50 %)

2/4 (50 %)

0/4 (0 %)

Week 2

1/7 (14 %)

6/7 (86 %)

0/7 (0 %)

3/7 (43 %)

4/7 (57 %)

0/7 (0 %)

Week 3

2/4 (50 %)

2/4 (50 %)

0/4 (0 %)

2/4 (50 %)

1/4 (25 %)

1/4 (25 %)

Week 4

2/4 (50 %)

1/4 (25 %)

1/4 (25 %)

2/4 (50 %)

2/4 (50 %)

0/4 (0 %)

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us